Advertisement

Psychopharmacology

, Volume 177, Issue 3, pp 245–255 | Cite as

Forced swimming test in mice: a review of antidepressant activity

  • Benoit Petit-Demouliere
  • Franck Chenu
  • Michel BourinEmail author
Review

Abstract

Rationale

Among all animal models, the forced swimming test (FST) remains one of the most used tools for screening antidepressants.

Objective

This paper reviews some of the main aspects of the FST in mice. Most of the sensitivity and variability factors that were assessed on the FST are summarized.

Mechanisms

We have summarized data found in the literature of antidepressant effects on the FST in mice. From this data set, we have extrapolated information on baseline levels of strain, and sensitivity against antidepressants.

Results

We have shown that many parameters have to be considered in this test to gain good reliability. Moreover, there was a fundamental inter-strain difference of response in the FST.

Conclusions

The FST is a good screening tool with good reliability and predictive validity. Strain is one of the most important parameters to consider. Swiss and NMRI mice can be used to discriminate the mechanisms of action of drugs. CD-1 seems to be the most useful strain for screening purposes, but this needs to be confirmed with some spontaneous locomotor activity studies.

Keywords

Forced swimming test Depression Mouse Antidepressants Screening Strain 

Abbreviations

5-HT

Serotonin

8-OH-DPAT

8-Hydroxy-2-(di-n-propylamino)tetralin

Atypical

Antidepressants with an atypical activity

BDNF

Brain-derived neurotrophic factor

DRI

Dopamine re-uptake inhibitors

FST

Forced swimming test

MAO-I

Monoamine oxidase inhibitors

NA

Noradrenaline

NOS synthase

Nitric oxide synthase

NRI

Noradrenaline re-uptake inhibitors

SNRI

Serotonin and noradrenaline re-uptake inhibitors

SSRI

Selective serotonin re-uptake inhibitors

TCAs

Tricyclic agents

TST

Tail suspension test

Supplementary material

213_2004_2048_ESM.pdf (25 kb)
(PDF 121 KB)

References

  1. Alcaro A, Cabib S, Ventura R, Puglisi-Allegra S (2002) Genotype- and experience-dependent susceptibility to depressive-like responses in the forced-swimming test. Psychopharmacology 164:138–143CrossRefPubMedGoogle Scholar
  2. Aley KO, Kulkarni SK (1989) GABA-mediated modification of despair behavior in mice. Naunyn Schmiedebergs Arch Pharmacol 339:306–311PubMedGoogle Scholar
  3. Alonso SJ, Castellano MA, Afonso D, Rodriguez M (1991) Sex differences in behavioral despair: relationships between behavioral despair and open field activity. Physiol Behav 49:69–72CrossRefPubMedGoogle Scholar
  4. Andreatini R, Bacellar LF (2000) Animal models: trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair. Prog Neuropsychopharmacol Biol Psychiatry 24:549–560CrossRefPubMedGoogle Scholar
  5. Anjaneyulu M, Chopra K, Kaur I (2003) Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food 6:391–395CrossRefPubMedGoogle Scholar
  6. Arai I, Tsuyuki Y, Shiomoto H, Satoh M, Otomo S (2000) Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice. Pharmacol Res 42:171–176CrossRefPubMedGoogle Scholar
  7. Baez M, Volosin M (1994) Corticosterone influences forced swim-induced immobility. Pharmacol Biochem Behav 49:729–736CrossRefPubMedGoogle Scholar
  8. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of “behavioral despair”. Pharmacol Biochem Behav 70:187–192CrossRefPubMedGoogle Scholar
  9. Biziere K, Kan JP, Souilhac J, Muyard JP, Roncucci R (1982) Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug. Arzneimittelforschung 32:824–831PubMedGoogle Scholar
  10. Biziere K, Worms P, Kan JP, Mandel P, Garattini S, Roncucci R (1985) Minaprine, a new drug with antidepressant properties. Drugs Exp Clin Res 11:831–840PubMedGoogle Scholar
  11. Bloch RG, Dooneief AS, Buchberg AS, Spellman S (1954) The clinical effect of isoniazid and iproniazid in the treatment of pulmonary tuberculosis. Ann Int Med 40:881–900PubMedGoogle Scholar
  12. Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147–160CrossRefPubMedGoogle Scholar
  13. Bourin M (1990) Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? Fundam Clin Pharmacol 4:49–64PubMedGoogle Scholar
  14. Bourin M, Colombel MC, Malinge M, Bradwejn J (1991) Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. J Psychiatry Neurosci 16:199–203PubMedGoogle Scholar
  15. Bourin M, Redrobe JP, Hascoet M, Baker GB, Colombel MC (1996) A schematic representation of the psychopharmacological profile of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 20:1389–1402CrossRefPubMedGoogle Scholar
  16. Bourin M, Colombel MC, Redrobe JP, Nizard J, Hascoet M, Baker GB (1998) Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. Prog Neuropsychopharmacol Biol Psychiatry 22:343–351CrossRefPubMedGoogle Scholar
  17. Bourin M, Fiocco AJ, Clenet F (2001) How valuable are animal models in defining antidepressant activity? Hum Psychopharmacol 16:9–21CrossRefPubMedGoogle Scholar
  18. Browne RG (1979) Effects of antidepressants and anticholinergics in a mouse “behavioral despair” test. Eur J Pharmacol 58:331–334CrossRefPubMedGoogle Scholar
  19. Bunney WE, Jr, Davis JM (1965) Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry 13:483–494PubMedGoogle Scholar
  20. Cabib S, Orsini C, Le Moal M, Piazza PV (2000) Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 289:463–465CrossRefPubMedGoogle Scholar
  21. Cabib S, Puglisi-Allegra S, Ventura R (2002) The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav Brain Res 130:103–109Google Scholar
  22. Clenet F, De Vos A, Bourin M (2001) Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice. Eur Neuropsychopharmacol 11:145–152Google Scholar
  23. Coppen A (1967) The biochemistry of affective disorders. Br J Psychiatry 113:1237–1264PubMedGoogle Scholar
  24. Costa E, Garattini S, Valzelli L (1960) Interactions between reserpine, chlorpromazine, and imipramine. Experientia 16:461–463PubMedGoogle Scholar
  25. Crabbe JC, Wahlsten D, Dudek BC (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284:1670–1672CrossRefPubMedGoogle Scholar
  26. Cryan JF, Mombereau C (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9:326–3577CrossRefPubMedGoogle Scholar
  27. Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA (2001) Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 298:651–657PubMedGoogle Scholar
  28. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238–245CrossRefPubMedGoogle Scholar
  29. Dalvi A, Lucki I (1999) Murine models of depression. Psychopharmacology 147:14–16CrossRefPubMedGoogle Scholar
  30. Da-Rocha MA Jr, Puech AJ, Thiebot MH (1997) Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. J Psychopharmacol 11:211–218PubMedGoogle Scholar
  31. David DJ, Bourin M, Hascoet M, Colombel MC, Baker GB, Jolliet P (2001a) Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice. Psychopharmacology 153:443–449CrossRefPubMedGoogle Scholar
  32. David DJ, Nic Dhonnchadha BA, Jolliet P, Hascoet M, Bourin M (2001) Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behav Brain Res 119:203–211Google Scholar
  33. David DJ, Renard CE, Jolliet P, Hascoet M, Bourin M (2003) Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology 166:373–382PubMedGoogle Scholar
  34. De Graaf JS, Van Riezen H, Berendsen HHG, Van Delft AML (1985) A set of behavioural tests predicting antidepressant activity. Curr Trends Rev 5:291–301Google Scholar
  35. Denenberg VH, Talgo NW, Waters NS, Kenner GH (1990) A computer-aided procedure for measuring swim rotation. Physiol Behav 47:1023–1025CrossRefPubMedGoogle Scholar
  36. Detke MJ, Lucki I (1996) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43–46Google Scholar
  37. Devoize JL, Rigal F, Eschalier A, Trolese JF (1982) Naloxone inhibits clomipramine in mouse forced swimming test. Eur J Pharmacol 78:229–231CrossRefPubMedGoogle Scholar
  38. Devoize JL, Rigal F, Eschalier A, Trolese JF, Renoux M (1984) Influence of naloxone on antidepressant drug effects in the forced swimming test in mice. Psychopharmacology 84:71–75PubMedGoogle Scholar
  39. Dubocovich ML, Mogilnicka E, Areso PM (1990) Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Eur J Pharmacol 182:313–325CrossRefPubMedGoogle Scholar
  40. Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321–1330Google Scholar
  41. Easton A, Arbuzova J, Turek FW (2003) The circadian Clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav 2:11–19CrossRefPubMedGoogle Scholar
  42. Eisch AJ, Bolanos CA, de Wit J, Simonak RD, Pudiak CM, Barrot M, Verhaagen J, Nestler EJ (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54:994–1005PubMedGoogle Scholar
  43. Eschalier A, Rigal F, Devoize JL, Trolese JF, Grillon C (1983) Morphine pretreatment reduces clomipramine effect in mouse forced-swimming test. Eur J Pharmacol 91:505–507PubMedGoogle Scholar
  44. Gardier AM, Trillat AC, Malagie I, David D, Hascoet M, Colombel MC, Jolliet P, Jacquot C, Hen R, Bourin M (2001) Recepteurs 5-HT1B de la serotonine et effets antidepresseurs des inhibiteurs de recapture selectif de la serotonine. CR Acad Sci Paris Life 324:433–441Google Scholar
  45. Geyer MA, Markou A (2000) Animal models of psychiatric disorders. In: The American College of Neuropsychopharmacology (ed) The fourth generation of progress online. ACNPGoogle Scholar
  46. Guo W, Todd K, Bourin M, Hascoet M, Kouadio F (1996) Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade. Pharmacol Biochem Behav 54:725–7300PubMedGoogle Scholar
  47. Harkin AJ, Bruce KH, Craft B, Paul IA (1999) Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 372:207–213CrossRefPubMedGoogle Scholar
  48. Heninger GR, Delgado PL, Charney DS (1996) The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 29:2–11PubMedGoogle Scholar
  49. Hilakivi LA, Ota M, Lister RG (1989) Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral ’despair’. Pharmacol Biochem Behav 33:371–374CrossRefPubMedGoogle Scholar
  50. Hirani K, Khisti RT, Chopde CT (2002) Behavioral action of ethanol in Porsolt’s forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one. Neuropharmacology 43:1339–1350Google Scholar
  51. Holmes A (2003a) Mouse behavioral models of anxiety and depression. In: Crawley JN (ed) Mouse behavioral phenotyping. Society for Neuroscience, Washington D.C., pp 43–47Google Scholar
  52. Holmes PV (2003b) Rodent models of depression: reexamining validity without anthropomorphic inference. Crit Rev Neurobiol 15:143–174CrossRefPubMedGoogle Scholar
  53. Holmes A, Yang RJ, Murphy DL, Crawley JN (2002) Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27:914–9233CrossRefPubMedGoogle Scholar
  54. Hyman SE, Nestler EJ (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153:151–162PubMedGoogle Scholar
  55. Karolewicz B, Paul IA (2001) Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. Eur J Pharmacol 415:197–201CrossRefPubMedGoogle Scholar
  56. Kato M, Katayama T, Iwata H, Yamamura M, Matsuoka Y, Narita H (1998) In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin. J Pharmacol Exp Ther 284:983–990PubMedGoogle Scholar
  57. Khisti RT, Chopde CT, Jain SP (2000) Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 67:137–143CrossRefPubMedGoogle Scholar
  58. Klerman GL, Cole JO (1965) Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol Rev 17:101–141PubMedGoogle Scholar
  59. Krahe TE, Filgueiras CC, Schmidt SL (2002) Effects of rotational side preferences on immobile behavior of normal mice in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 26:169–176CrossRefPubMedGoogle Scholar
  60. Kuhn R (1957) Treatment of depressive states with an iminodibenzyl derivative (G 22355). Schweiz Med Wochenschr 87:1135–1140PubMedGoogle Scholar
  61. Loomer HP, Saunders JC, Kline NS (1957) A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc 135:129–141PubMedGoogle Scholar
  62. Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523–532PubMedGoogle Scholar
  63. Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155:315–322CrossRefPubMedGoogle Scholar
  64. Luttinger D, Freedman M, Hamel L, Ward SJ, Perrone M (1985) The effects of serotonin antagonists in a behavioral despair procedure in mice. Eur J Pharmacol 107:53–58CrossRefGoogle Scholar
  65. MacQueen GM, Ramakrishnan K, Croll SD, Siuciak JA, Yu G, Young LT, Fahnestock M (2001) Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115:1145–11533CrossRefPubMedGoogle Scholar
  66. Malinge M, Bourin M, Colombel MC, Larousse C (1988) Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test. Psychopharmacology 96:104–109PubMedGoogle Scholar
  67. Miura H, Naoi M, Nakahara D, Ohta T, Nagatsu T (1996) Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice. Pharmacol Biochem Behav 53:469–475CrossRefPubMedGoogle Scholar
  68. Mogilnicka E, Czyrak A, Maj J (1987) Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur J Pharmacol 138:413–416CrossRefPubMedGoogle Scholar
  69. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, Meuth S, Nagy A, Greene RW, Nestler EJ (2004) Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 101:10827–10832CrossRefPubMedGoogle Scholar
  70. Nestler EJ (1998) Antidepressant treatments in the 21st century. Biol Psychiatry 44:526–533CrossRefPubMedGoogle Scholar
  71. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, Hen R, Koester S, Lederhendler I, Meaney M, Robbins T, Winsky L, Zalcman S (2002) Preclinical models: status of basic research in depression. Biol Psychiatry 52:503–528CrossRefPubMedGoogle Scholar
  72. Nomura S, Shimizu J, Kinjo M, Kametani H, Nakazawa T (1982) A new behavioral test for antidepressant drugs. Eur J Pharmacol 83:171–175CrossRefPubMedGoogle Scholar
  73. O’Neil MF, Moore NA (2003) Animal models of depression: are there any? Hum Psychopharmacol 18:239–254CrossRefPubMedGoogle Scholar
  74. Porsolt RD (2000) Animal models of depression: utility for transgenic research. Rev Neurosci 11:53–58PubMedGoogle Scholar
  75. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336PubMedGoogle Scholar
  76. Porsolt RD, Bertin A, Jalfre M (1978) “Behavioural despair” in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51:291–294CrossRefPubMedGoogle Scholar
  77. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201–210CrossRefPubMedGoogle Scholar
  78. Raghavendra V, Kaur G, Kulkarni SK (2000) Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur Neuropsychopharmacol 10:473–481CrossRefPubMedGoogle Scholar
  79. Redrobe JP, Pinot P, Bourin M (1996) The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam Clin Pharmacol 10:524–5288PubMedGoogle Scholar
  80. Redrobe JP, Bourin M, Colombel MC, Baker GB (1998) Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology 138:1–8CrossRefPubMedGoogle Scholar
  81. Rogoz Z, Skuza G, Maj J (1999) Pharmacological profile of milnacipran, a new antidepressant, given acutely. Pol J Pharmacol 51:317–322PubMedGoogle Scholar
  82. Schechter MD, Chance WT (1979) Non-specificity of “behavioral despair” as an animal model of depression. Eur J Pharmacol 60:139–142CrossRefPubMedGoogle Scholar
  83. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522PubMedGoogle Scholar
  84. Schramm NL, McDonald MP, Limbird LE (2001) The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 21:4875–4882PubMedGoogle Scholar
  85. Scotto di Tella AM, Mercier J (1981) Influence of the procedure of administration in the activity of some antidepressant or disinhibiting drugs upon behavioural despair (author’s transl). J Pharmacol 12:179–188PubMedGoogle Scholar
  86. Selikoff IJ, Robitzek EH (1952) Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Dis Chest 21:385–438PubMedGoogle Scholar
  87. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131–137CrossRefPubMedGoogle Scholar
  88. Slattery DA, Hudson AL, Nutt DJ (2004) Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol 18:1–21PubMedGoogle Scholar
  89. Stenger A, Couzinier JP, Briley M (1987) Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant. Psychopharmacology 91:147–153CrossRefPubMedGoogle Scholar
  90. Sunal R, Gumusel B, Kayaalp SO (1994) Effect of changes in swimming area on results of “behavioral despair test”. Pharmacol Biochem Behav 49:891–896CrossRefPubMedGoogle Scholar
  91. Szymczyk G, Zebrowska-Lupina I (2000) Influence of antiepileptics on efficacy of antidepressant drugs in forced swimming test. Pol J Pharmacol 52:337–344PubMedGoogle Scholar
  92. Taltavull JF, Chefer VI, Shippenberg TS, Kiyatkin EA (2003) Severe brain hypothermia as a factor underlying behavioral immobility during cold-water forced swim. Brain Res 975:244–247CrossRefPubMedGoogle Scholar
  93. Thierry B, Steru L, Simon P, Porsolt RD (1986) The tail suspension test: ethical considerations. Psychopharmacology 90:284–285CrossRefPubMedGoogle Scholar
  94. Voikar V, Koks S, Vasar E, Rauvala H (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72:271–281CrossRefPubMedGoogle Scholar
  95. Wahlsten D, Metten P, Phillips TJ, Boehm SL II, Burkhart-Kasch S, Dorow J, Doerksen S, Downing C, Fogarty J, Rodd-Henricks K, Hen R, McKinnon CS, Merrill CM, Nolte C, Schalomon M, Schlumbohm JP, Sibert JR, Wenger CD, Dudek BC, Crabbe JC (2003) Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol 54:283–311CrossRefPubMedGoogle Scholar
  96. West AP (1990) Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 14:863–877CrossRefPubMedGoogle Scholar
  97. Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1–16PubMedGoogle Scholar
  98. Willner P, Mitchell PJ (2002) The validity of animal models of predisposition to depression. Behav Pharmacol 13:169–1888PubMedGoogle Scholar
  99. Wong ML, Licinio J (2004) From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3:136–151CrossRefPubMedGoogle Scholar
  100. Yates G, Panksepp J, Ikemoto S, Nelson E, Conner R (1991) Social isolation effects on the “behavioral despair” forced swimming test: effect of age and duration of testing. Physiol Behav 49:347–353CrossRefPubMedGoogle Scholar
  101. Yoshikawa T, Watanabe A, Ishitsuka Y, Nakaya A, Nakatani N (2002) Identification of multiple genetic loci linked to the propensity for “behavioral despair” in mice. Genome Res 12:357–366CrossRefPubMedGoogle Scholar
  102. Zeller EA, Barsky J (1952) In vivo inhibition of liver and brain monoamine oxidase by 1-Isonicotinyl-2-isopropyl hydrazine. Proc Soc Exp Biol Med 81:459–461PubMedGoogle Scholar
  103. Zocchi A, Varnier G, Arban R, Griffante C, Zanetti L, Bettelini L, Marchi M, Gerrard PA, Corsi M (2003) Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse. Neurosci Lett 345:73–76CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Benoit Petit-Demouliere
    • 1
  • Franck Chenu
    • 1
  • Michel Bourin
    • 1
    Email author
  1. 1.EA 3256 “Neurobiologie de l’anxiété et de la dépression”Faculté de MédecineNantes Cedex 01France

Personalised recommendations